This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
List/tripsitting: Difference between revisions
Jump to navigation
Jump to search
>David Hedlund significantly: CBD:THC ratio significantly higher |
>David Hedlund CBD heated to 250-300 C will partially be converted to THC. - pmid=33903673 |
||
| Line 120: | Line 120: | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Cannabinoid antidotes|Antidotes]]</h4> | <h4 class="media-heading">[[Cannabinoid antidotes|Antidotes]]</h4> | ||
*[[CBD]] (''non-inhalant ROA, | *[[CBD]] (''non-inhalant ROA'') | ||
** CBD heated to 250-300 C will partially be converted to THC.<ref>{{cite journal |last1=Czégény |first1=Z |last2=Nagy |first2=G |last3=Babinszki |first3=B |last4=Bajtel |first4=Á |last5=Sebestyén |first5=Z |last6=Kiss |first6=T |last7=Csupor-Löffler |first7=B |last8=Tóth |first8=B |last9=Csupor |first9=D |title=CBD, a precursor of THC in e-cigarettes. |journal=Scientific reports |date=26 April 2021 |volume=11 |issue=1 |pages=8951 |doi=10.1038/s41598-021-88389-z |pmid=33903673 |pmc=8076212}}</ref> | |||
** CBD:THC ratio: 50:1<ref>{{cite journal | vauthors=((Englund, A.)), ((Oliver, D.)), ((Chesney, E.)), ((Chester, L.)), ((Wilson, J.)), ((Sovi, S.)), ((De Micheli, A.)), ((Hodsoll, J.)), ((Fusar-Poli, P.)), ((Strang, J.)), ((Murray, R. M.)), ((Freeman, T. P.)), ((McGuire, P.)) | journal=Neuropsychopharmacology | title=Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios | pages=1–8 | date=16 November 2022 | url=https://www.nature.com/articles/s41386-022-01478-z | issn=1740-634X | doi=10.1038/s41386-022-01478-z | access-date=25 November 2022}}</ref> | |||
</li> | </li> | ||
</ul> | </ul> | ||
Revision as of 05:49, 23 December 2022
Psychedelic tripsitting 
-
Psychological first aid
-
Long-term therapies
-
Neuroaesthetics
-
Antidotes
- Anticonvulsants/antiepileptics: Common
- Antipsychotics: Common
- Anxiolytics: Common
- Hydroxyzine (for paranoia along with antipsychotic mechanisms)
- Serotonin syndrome treatment: Common
Deliriant tripsitting 
-
Antidotes
- Physostigmine (for diphenhydramine overdose)
Miscellaneous hallucinogen tripsitting 
Depressant tripsitting 
-
Antidotes
- Atropine (for nerve agent poisoning)
- N-acetylcysteine (for acetaminophen overdose)
-
GABAergic tripsitting
- Anticonvulsants/antiepileptics: Common
- Flumazenil (for benzodiazepine overdose)
-
Opioid tripsitting
-
Miscellaneous depressant tripsitting
- ↑ Czégény, Z; Nagy, G; Babinszki, B; Bajtel, Á; Sebestyén, Z; Kiss, T; Csupor-Löffler, B; Tóth, B; Csupor, D (26 April 2021). "CBD, a precursor of THC in e-cigarettes". Scientific reports. 11 (1): 8951. doi:10.1038/s41598-021-88389-z. PMC 8076212
Check |pmc=value (help). PMID 33903673. - ↑ Englund, A., Oliver, D., Chesney, E., Chester, L., Wilson, J., Sovi, S., De Micheli, A., Hodsoll, J., Fusar-Poli, P., Strang, J., Murray, R. M., Freeman, T. P., McGuire, P. (16 November 2022). "Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios". Neuropsychopharmacology: 1–8. doi:10.1038/s41386-022-01478-z. ISSN 1740-634X. Retrieved 25 November 2022.